Cost-Effectiveness of Ponatinib in the Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.219
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV